Navigation Links
Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results
Date:11/9/2009

Non-GAAP adjusted earnings per share- Diluted $0.28 (1) $0.30 (1) ===== ===== NET INCOME GAAP net income (loss) $34,940 $(144,374) Adjustments: Fair value write-up of acquired Third Wave inventory 83 3,933 Amortization of intangible assets acquired since fiscal 2006 51,805 31,968 Stock-based compensation associated with the termination of former Third Wave officers - 480 Operating charges relating to the closure of the Company's organic photoconductor drum coatings manufacturing operations in Shanghai and related costs 2,002 - Acquired in-process research and development - 195,200 Income tax effect primarily related to reconciling items (16,387)(2) (9,995)(3) ------- ------ Non-GAAP adjusted net income $72,443 $77,212 ======= ======= EBITDA Non-GAAP adjusted net income $72,443 Interest expense, net 16,283 Provision for income taxes 41,700 Depreciation and amortization not adjusted above 18,828 ------ Adjusted EBITDA $149,254 ======== EXPLANATORY NOTES: (1) Non-GAAP adjusted earnings per share was calculated based on 259,884 and 259,242 weighted average diluted shares outstanding for the three mont
'/>"/>
SOURCE Hologic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
2. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
5. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
6. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Hologic Expands Healthcare Investment in Asia
9. Hologic to Host Investor Reception at RSNA 2009
10. Hologic to Present at Citis 2009 Sixth Annual Small/Mid Cap Conference
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire-iReach/ -- The ... by universal healthcare coverage and good access to ... population and its associated disease burden, well-defined regulatory ... introduction of a new manufacturing policy will drive ... However, a focus on generic substitution and price ...
(Date:9/2/2014)... , Sept. 2, 2014  Cyberonics, Inc. ... from the ANTHEM-HF clinical study.  Results of the ... during a major European cardiology congress and concurrently ... show Autonomic Regulation Therapy (ART) in patients ... impaired heart function is safe, improves the heart,s ...
(Date:9/2/2014)... , Sept. 2, 2014  Based on ... treatment device market, Frost & Sullivan recognizes Novian ... & Sullivan Award for Technology Innovation Leadership. Novian ... fibroadenoma and malignant tumors with its proprietary technology, ... is a reliable, accurate, and easy-to-control ultrasound-guided thermo ...
Breaking Medicine Technology:Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 2Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 3Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 4Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 5ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 3ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 5Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5
... , CINCINNATI , June 21 ... to its HARMONIC® line of surgical devices, the HARMONIC ... designed to extend the reach of surgeons for minimally ... (or 9cm) than the standard length HARMONIC ACE® device. ...
... today announced that six-month clinical follow-up data show the safety and ... (Sequent Please®, B.Braun) followed by implantation of the company,s Genous Bio-engineered ... , , ... single center, all-comers POTENT ( P aclitaxel-eluting ball O on and ...
Cached Medicine Technology:Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS 2Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS 3Data Show OrbusNeich's Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon 2Data Show OrbusNeich's Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon 3
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... other new blood thinners is growing at a rapid ... continue to mount in courts around the U.S., Bernstein ... in American Journal of Medicine, within a year of ... be prescribed Xarelto as warfarin, a blood thinner that ...
(Date:9/2/2014)... 2014 (HealthDay News) -- Complications are rare among ... a new study indicates. However, the researchers ... with a slightly higher risk for certain complications ... more than 18,000 breast cancer patients who had ... with breast reconstruction and were followed for 30 ...
(Date:9/2/2014)... September 2, 2014 In a large population-based ... found that mild cognitive impairment (MCI) occurred twice ... type 2. Interestingly, this strong association was only ... older participants (66-80 years) the association vanished. This ... Alzheimer,s Disease . , The concept of MCI ...
(Date:9/2/2014)... Medex Analytic Services is delighted to ... Coral Springs, Fla. due to their greater than forecasted ... for the 2014 year by distinguishing Medex in the ... a higher level of service and professionalism in the ... the industry has responded.” , The location of the ...
(Date:9/2/2014)... Kathleen Doheny HealthDay Reporter ... obesity epidemic is a driving force behind the rising rates ... Researchers looked at data from five national surveys spanning from ... diabetes over time could be explained by factors such as ... The investigators found that the prevalence of diabetes in ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2Health News:Diabetes mellitus and mild cognitive impairment: Higher risk in middle age? 2Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3
... HBV is small in size. The genome of this virus ... stranded, this genome carries about 3000 base pairs, compared to ... virus. These 3000 base pairs encode an envelope protein, a ... very special X protein, named such because its function was ...
... a curriculum-based bullying prevention program reduced incidents of bullying by ... group. , Jeffrey M. Jenson and William A. Dieterich of ... more than 1,100 students in 28 elementary schools in Denver ... prevention program called Youth Matters (YM). A second control ...
... is the first to document a genetic mutation linked to ... it is likely to give them new insight into how ... Annex, professor of medicine and director of vascular medicine at ... Over and over, Id see two patients show up ...
... higher prevalence of stroke than their European counterparts, due in ... Americans and barriers to care in the United States, according ... Stroke Conference 2008. , Compared to European men, U.S. men ... U.S. women had almost twice the odds of stroke as ...
... of public town hall meetings to gather feedback from the public ... the role of genes and environment in health. The town halls ... Institutes of Health and other federal health agencies discussions as they ... , One way to study a host of common diseases - ...
... Finding may provide benefit for HIV, bone marrow transplantation ... possible to stimulate the thymus gland to produce new ... researchers say. , HIV infection destroys T-cells, which leads ... infection. The thymus gland produces T-cells early in life ...
Cached Medicine News:Health News:Who found some new mechanisms of HBV virulence? 2Health News:University of Denver bullying victimization study 2Health News:Genetic mutation found in peripheral artery disease 2Health News:Stroke more prevalent in United States than in Europe 2Health News:Stroke more prevalent in United States than in Europe 3Health News:Genetic town halls to be held in 5 US cities 2Health News:Stimulating Thymus Reactivates T-Cell Production 2
... system delivers on the promise of ... the latest advancement in fluidics control ... Lomb Surgical offers CONCENTRIX™ Fluidics Control ... provide both flow and vacuum response. ...
... excellent maneuverability. Konan made it ... high quality. Easy switchover from ... changing the adapter. Konan's development ... in a sharp image from ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... These plugs are coated with ... (PVP) that makes the surface ... drainage and to prevent debris ... For partial occlusion. For partial ...
Medicine Products: